[HTML][HTML] An update on pancreatic regeneration mechanisms: searching for paths to a cure for type 2 diabetes

L Soldovieri, G Di Giuseppe, G Ciccarelli, G Quero… - Molecular …, 2023 - Elsevier
Background Over the last decades, various approaches have been explored to restore
sufficient β-cell mass in diabetic patients. Stem cells are certainly an attractive source of new …

Pharmacotherapy of Zollinger–Ellison syndrome

T Ito, H Igarashi, H Uehara… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: The role of pharmacotherapy in the management of patients with Zollinger–
Ellison syndrome (ZES) is often equated with the medical management of acid …

α-Internexin: a novel biomarker for pancreatic neuroendocrine tumor aggressiveness

B Liu, LH Tang, Z Liu, M Mei, R Yu… - The Journal of …, 2014 - academic.oup.com
Purpose: We aimed to test whether α-internexin could be a molecular biomarker of tumor
aggressiveness and prognosis in pancreatic neuroendocrine tumors (PNETs). Patients and …

[HTML][HTML] Genetic and epigenetic alterations in pancreatic neuroendocrine tumors

A Tirosh, E Kebebew - Journal of gastrointestinal oncology, 2020 - ncbi.nlm.nih.gov
Neuroendocrine tumors (NETs) are a heterogenous group of tumors that originate from
neuroendocrine cells, mainly in the pancreas and the gastrointestinal and …

[HTML][HTML] Epigenetic regulation in gastroenteropancreatic neuroendocrine tumors

JS Crabtree - Frontiers in Oncology, 2022 - frontiersin.org
Gastroenteropancreatic neuroendocrine neoplasms are a rare, diverse group of
neuroendocrine tumors that form in the pancreatic and gastrointestinal tract, and often …

Zollinger–Ellison syndrome

RT Jensen - Yamada's Textbook of Gastroenterology, 2015 - Wiley Online Library
Zollinger‐Ellison syndrome (ZES) can occur without an accompanying inherited syndrome
(ie, sporadic ZES) or as part of the multiple endocrine neoplasia type 1 syndrome (MEN1) …

[HTML][HTML] Current and new challenges in the management of pancreatic neuroendocrine tumors: the role of miRNA-based approaches as new reliable biomarkers

A Havasi, D Sur, SS Cainap, CV Lungulescu… - International Journal of …, 2022 - mdpi.com
Pancreatic neuroendocrine tumors (PanNETs) are rare tumors; however, their incidence
greatly increases with age, and they occur more frequently among the elderly. They …

DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment

EB Conemans, L Lodewijk, CB Moelans… - European journal of …, 2018 - academic.oup.com
Objective Epigenetic changes contribute to pancreatic neuroendocrine tumor (PanNET)
development. Hypermethylation of promoter DNA as a cause of tumor suppressor gene …

Pancreatic neuroendocrine tumors: pathologic and molecular characteristics

C Shi, DS Klimstra - Seminars in Diagnostic Pathology, 2014 - Elsevier
Pancreatic neuroendocrine neoplasms include mainly well-differentiated neuroendocrine
tumors but also rare poorly differentiated neuroendocrine carcinomas. Molecular …

[HTML][HTML] Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms

A Childs, CD Steele, C Vesely… - Endocrine-Related …, 2021 - erc.bioscientifica.com
Single-cell profiling of circulating tumor cells (CTCs) as part of a minimally invasive liquid
biopsy presents an opportunity to characterize and monitor tumor heterogeneity and …